Novartis’ ophthalmology division Alcon has announced plans to build a digital platform to streamline, simplify and improve cataract surgery for surgeons and patients.
We recommend a 'Strong Buy' rating for Alcon with a $118 price target, citing new product launches and steady growth in ...
Mizuho Securities analyst Anthony Petrone has maintained their bullish stance on ALC stock, giving a Buy rating yesterday. Anthony Petrone has ...
Hosted on MSN3mon
Alcon (ALC) Q2 Earnings Meet Estimates, Revenues Increase Y/YIn June 2024, Alcon’s innovations from the highly anticipated UNITY portfolio, Vitreoretinal Cataract System and Cataract System, secured the FDA’s 510(k) clearance. In the second half of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback